Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An inherited retinopathy caused by bi-allelic variants in the GNAT2 gene.
Biomarker and diagnostic research for GNAT2-related retinopathy has been reported in the published literature.
No clinical trials have been registered for GNAT2-related retinopathy.
209 publications have been identified in PubMed for GNAT2-related retinopathy. Kisho has analyzed 137 by research type. Research spans Review / Meta-Analysis (50%), Basic Science / Preclinical (17%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 68 | 50% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 11:13 AM UTC
Common questions about GNAT2-related retinopathy
Laboratory research
23 |
17% |
Disease patterns and progression | 22 | 16% |
Testing and diagnosis research | 8 | 6% |
Patient case studies | 7 | 5% |
New treatment approaches | 4 | 3% |
Clinical study results | 3 | 2% |
Other research | 2 | 1% |
Khan AO (2026). [PMID: 41166683](https://pubmed.ncbi.nlm.nih.gov/41166683/). *Retina*. [Basic Science / Preclinical]
Selim MS (2026). [PMID: 41827851](https://pubmed.ncbi.nlm.nih.gov/41827851/). *Cells*. [Review / Meta-Analysis]
Land MR (2026). [PMID: 41750360](https://pubmed.ncbi.nlm.nih.gov/41750360/). *Biomolecules*. [Review / Meta-Analysis]
Hashemi S (2026). [PMID: 41648531](https://pubmed.ncbi.nlm.nih.gov/41648531/). *bioRxiv : the preprint server for biology*. [Basic Science / Preclinical]
Zhao CS (2026). [PMID: 41608829](https://pubmed.ncbi.nlm.nih.gov/41608829/). *Curr Opin Ophthalmol*. [Review / Meta-Analysis]
Marmor MF (2026). [PMID: 41232611](https://pubmed.ncbi.nlm.nih.gov/41232611/). *Ophthalmology*. [Review / Meta-Analysis]
Mukundan A (2026). [PMID: 41316839](https://pubmed.ncbi.nlm.nih.gov/41316839/). *Ocul Immunol Inflamm*. [Review / Meta-Analysis]
Niaudet C (2026). [PMID: 41271176](https://pubmed.ncbi.nlm.nih.gov/41271176/). *Radiother Oncol*. [Review / Meta-Analysis]
Wang X (2026). [PMID: 41662529](https://pubmed.ncbi.nlm.nih.gov/41662529/). *Proc Natl Acad Sci U S A*. [Basic Science / Preclinical]
Biber J (2025). [PMID: 40268248](https://pubmed.ncbi.nlm.nih.gov/40268248/). *Pharmacol Ther*. [Review / Meta-Analysis]